A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient with IHC-Positive and FISH-Negative ALK-Reference-Cited by-同舟云学术

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient with IHC-Positive and FISH-Negative ALK

Published:2012-12 Issue:12 Volume:7 Page:e36-e38
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sun Jong-Mu,Choi Yoon-La,Won Jae-Kyung,Hirsch Fred R.,Ahn Jin Seok,Ahn Myung-Ju,Park Keunchil

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference5 articles.

1. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

2. Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC);Crino;PROFILE 1005 ASCO Meeting Abstracts,2011

3. A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry;Mino-Kenudson;Clin Cancer Res,2010

4. Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study;McLeer-Florin;J Thorac Oncol,2012

5. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization;Paik;J Thorac Oncol,2011

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discordant ALK Status in Non-Small Cell Lung Carcinoma: A Detailed Reevaluation Comparing IHC, FISH, and NGS Analyses;International Journal of Molecular Sciences;2024-07-26

2. Immunohistochemical expression of anaplastic lymphoma kinase in neuroblastoma and its relations with some clinical and histopathological features;Journal of Pathology and Translational Medicine;2024-01-15

3. Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing;International Journal of Clinical Oncology;2024-01-06

4. Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing;2023-09-01

5. State of the Art of Pathologic and Molecular Testing;Hematology/Oncology Clinics of North America;2023-06